MX388832B - Deteccion especifica de isoformas de clusterina. - Google Patents
Deteccion especifica de isoformas de clusterina.Info
- Publication number
- MX388832B MX388832B MX2017013729A MX2017013729A MX388832B MX 388832 B MX388832 B MX 388832B MX 2017013729 A MX2017013729 A MX 2017013729A MX 2017013729 A MX2017013729 A MX 2017013729A MX 388832 B MX388832 B MX 388832B
- Authority
- MX
- Mexico
- Prior art keywords
- specific detection
- clusterin isoforms
- clusterin
- isoforms
- detection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
- G01N33/523—Single-layer analytical elements the element being adapted for a specific analyte
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/534—Production of labelled immunochemicals with radioactive label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
- G01N2333/42—Lectins, e.g. concanavalin, phytohaemagglutinin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562155175P | 2015-04-30 | 2015-04-30 | |
| PCT/US2016/030075 WO2016176565A1 (en) | 2015-04-30 | 2016-04-29 | Specific detection of clusterin isoforms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017013729A MX2017013729A (es) | 2018-05-22 |
| MX388832B true MX388832B (es) | 2025-03-20 |
Family
ID=56069221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017013729A MX388832B (es) | 2015-04-30 | 2016-04-29 | Deteccion especifica de isoformas de clusterina. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20180142009A1 (enExample) |
| EP (2) | EP3289363B1 (enExample) |
| JP (2) | JP6948265B2 (enExample) |
| KR (1) | KR102462056B1 (enExample) |
| CN (1) | CN108093648B (enExample) |
| AU (1) | AU2016254150B2 (enExample) |
| CA (1) | CA2983828A1 (enExample) |
| DK (1) | DK3289363T3 (enExample) |
| ES (1) | ES2907068T3 (enExample) |
| MX (1) | MX388832B (enExample) |
| WO (1) | WO2016176565A1 (enExample) |
| ZA (1) | ZA201707313B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6948265B2 (ja) * | 2015-04-30 | 2021-10-13 | アイデックス ラボラトリーズ インコーポレイテッドＩＤＥＸＸ Ｌａｂｏｒａｔｏｒｉｅｓ， Ｉｎｃ． | クラステリンアイソフォームの特異的検出 |
| EP3232200A1 (en) * | 2016-04-12 | 2017-10-18 | Institut Catalá De Ciencies Cardiovasculars (ICCC) | Methods and kits for the diagnosis and risk stratification of patients with ischemia |
| FR3069156B1 (fr) * | 2017-07-21 | 2019-08-09 | Universite de Bordeaux | Clusterine pour son utilisation dans le traitement des micro-angiopathies thrombotiques |
| CN109239362B (zh) * | 2018-10-22 | 2021-05-07 | 西北大学 | 一种凝集素探针组合在基于尿蛋白糖型鉴别秦岭川金丝猴妊娠方面的应用 |
| CN110045127A (zh) * | 2019-04-03 | 2019-07-23 | 中国医学科学院北京协和医院 | 一种IgG4相关性疾病多器官受累的生物标志物及其用途 |
| CN121160872A (zh) * | 2025-10-10 | 2025-12-19 | 复旦大学附属妇产科医院 | Clu基因作为标志物在筛选或治疗宫颈胃型腺癌中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
| JP2714664B2 (ja) * | 1988-04-13 | 1998-02-16 | 塩野義製薬株式会社 | マイコプラズマ由来マクロファージ活性化因子 |
| US5726010A (en) | 1991-07-31 | 1998-03-10 | Idexx Laboratories, Inc. | Reversible flow chromatographic binding assay |
| AU2003281287A1 (en) * | 2002-07-04 | 2004-01-23 | Oxford Glycosciences (Uk) Ltd | Toxicity markers |
| ITRM20040098A1 (it) * | 2004-02-25 | 2004-05-25 | Univ Roma | Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi. |
| ES2743543T3 (es) * | 2005-05-05 | 2020-02-19 | Univ Drexel | Diagnóstico de patología hepática a través de la evaluación del quininógeno fucosilado |
| JP5752600B2 (ja) * | 2008-11-10 | 2015-07-22 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後のための方法 |
| US8168396B2 (en) * | 2009-05-11 | 2012-05-01 | Diabetomics, Llc | Methods for detecting pre-diabetes and diabetes using differential protein glycosylation |
| WO2012102963A1 (en) * | 2011-01-26 | 2012-08-02 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Urine biomarkers for prediction of recovery after acute kidney injury : proteomics |
| WO2014197729A1 (en) * | 2013-06-05 | 2014-12-11 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN104267187A (zh) * | 2014-10-15 | 2015-01-07 | 吉林大学 | 检测尿液Clusterin含量试纸条的制备及应用 |
| JP6948265B2 (ja) * | 2015-04-30 | 2021-10-13 | アイデックス ラボラトリーズ インコーポレイテッドＩＤＥＸＸ Ｌａｂｏｒａｔｏｒｉｅｓ， Ｉｎｃ． | クラステリンアイソフォームの特異的検出 |
-
2016
- 2016-04-29 JP JP2017556249A patent/JP6948265B2/ja active Active
- 2016-04-29 AU AU2016254150A patent/AU2016254150B2/en active Active
- 2016-04-29 CA CA2983828A patent/CA2983828A1/en active Pending
- 2016-04-29 ES ES16724520T patent/ES2907068T3/es active Active
- 2016-04-29 WO PCT/US2016/030075 patent/WO2016176565A1/en not_active Ceased
- 2016-04-29 CN CN201680038724.2A patent/CN108093648B/zh active Active
- 2016-04-29 EP EP16724520.8A patent/EP3289363B1/en active Active
- 2016-04-29 EP EP21206365.5A patent/EP4019976A1/en active Pending
- 2016-04-29 MX MX2017013729A patent/MX388832B/es unknown
- 2016-04-29 DK DK16724520.8T patent/DK3289363T3/da active
- 2016-04-29 KR KR1020177031499A patent/KR102462056B1/ko active Active
- 2016-04-29 US US15/568,653 patent/US20180142009A1/en active Pending
-
2017
- 2017-10-27 ZA ZA2017/07313A patent/ZA201707313B/en unknown
-
2021
- 2021-01-29 JP JP2021012877A patent/JP2021099342A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3289363B1 (en) | 2021-11-24 |
| ZA201707313B (en) | 2022-02-23 |
| US20180142009A1 (en) | 2018-05-24 |
| CA2983828A1 (en) | 2016-11-03 |
| DK3289363T3 (da) | 2022-02-28 |
| KR20180003549A (ko) | 2018-01-09 |
| JP6948265B2 (ja) | 2021-10-13 |
| JP2018515762A (ja) | 2018-06-14 |
| EP4019976A1 (en) | 2022-06-29 |
| BR112017021850A2 (pt) | 2018-07-10 |
| NZ736200A (en) | 2021-11-26 |
| AU2016254150A1 (en) | 2017-10-26 |
| MX2017013729A (es) | 2018-05-22 |
| ES2907068T3 (es) | 2022-04-21 |
| CN108093648B (zh) | 2020-04-10 |
| AU2016254150B2 (en) | 2021-09-30 |
| WO2016176565A1 (en) | 2016-11-03 |
| EP3289363A1 (en) | 2018-03-07 |
| KR102462056B1 (ko) | 2022-11-02 |
| CN108093648A (zh) | 2018-05-29 |
| JP2021099342A (ja) | 2021-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202107931B (en) | Anti-tau antibodies and methods of use | |
| CY1125136T1 (el) | Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη | |
| CY1124215T1 (el) | Μκ2 αναστολεις και χρησεις αυτων | |
| CY1124013T1 (el) | Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη | |
| CY1124131T1 (el) | Συζευγματα αντι-ρτκ7 αντισωματος-φαρμακου | |
| CY1122148T1 (el) | Συνθεσεις που περιεχουν βακτηριακα στελεχη | |
| MX384884B (es) | Inhibidores de ret. | |
| PH12017500861A1 (en) | Anti-interleukin-33 antibodies and uses thereof | |
| MX379270B (es) | Composiciones que comprenden cepas bacterianas. | |
| PH12017500877B1 (en) | ANTI-CD79b ANTIBODIES AND METHODS OF USE | |
| MX2017005920A (es) | Anticuerpos anti-tim3 y metodos de uso. | |
| PL3386534T3 (pl) | Kompozycje i sposoby internalizacji enzymów | |
| MX2016015162A (es) | Anticuerpos anti - gpc3 e inmunoconjugados. | |
| MY176855A (en) | Anti-jagged1 antibodies and methods of use | |
| MX382996B (es) | Inhibidores de pcna | |
| HUE042606T2 (hu) | Eljárás apolipoprotein kimutatására | |
| MX2017013729A (es) | Deteccion especifica de isoformas de clusterina. | |
| PH12017501864A1 (en) | Compositions and methods for treating autism | |
| MX2016016233A (es) | Anticuerpos anti-lgr5 y sus usos. | |
| EA201891478A1 (ru) | Способы и композиции для оценки риска возникновения рака | |
| DK3349731T3 (da) | Kombination af topoisomerase-i-inhibitorer med immunoterapi til behandlingen af kræft | |
| MX383460B (es) | Derivados peptidicos novedosos y sus usos. | |
| EP3432728C0 (en) | ENZYMATIC COMPOSITIONS | |
| EP3373956A4 (en) | PROENZYMZUSAMMENSETZUNG | |
| TH1601001795B (th) | วิธีสำหรับการตรวจวัดและกำหนดหาปริมาณของกาแลคโต-โอลิโกแซคคาไรด์ |